News
Swiss Deep Tech News & Analysis
Stay informed on the Swiss technology landscape. This is your central resource for Deep Tech News, combining key developments from across the ecosystem with original, data-driven analysis from the Deep Tech Nation Foundation. We track and report on significant technological milestones, funding rounds, and research to provide a comprehensive overview for international investors, partners, and researchers.
Curated Newsfeed
-
Vaderis Therapeutics closes USD 152 million Series B Financing
startupticker.ch
-
Terra Quantum partners with Apex.AI on quantum-safe security
startupticker.ch
-
AB2 Bio receives USD 30 million from Nippon Shinyaku
startupticker.ch
DTN Highlights
-
Read more: swisscanto: A Matter of ScaleThe Flywheel Switzerland Hasn’t Built Roughly seventy percent of the Swiss Growth Fund’s money is invested in Switzerland, and Nils Granath is clear that this…
-
Read more: swisscanto: Backed to the FutureThree Companies That Almost Stopped Running Nils Granath invests in the growth stage of the Swiss market, and it is the part where the money…
-
Read more: swisscanto: At Face ValueThe Marathon Runner In the mid-1990s, the European mobile telecoms industry was hiring at a pace that was breaking its own buildings. Ericsson, the Swedish…
-
Read more: Swiss Venture Capital Steadies at $1.58 Billion in H1 2026 as Hardware Sets a RecordSwiss venture capital returned to a familiar level in the first half of 2026. Startups raised $1.58 billion (CHF 1.245 billion) across 123 financing rounds,…
-
Read more: Swiss Deep Tech Report 2026: Switzerland Leads the Technologies Reshaping the Global EconomyThe technologies now driving the global economy, advanced computing, artificial intelligence, and robotics, are built patiently, over decades of investment and scientific groundwork. So are…
-
Read more: Swiss Venture Capital Matures: Returns, Exits, and a Sharper Investor LayerSwiss venture capital recorded its first annual rebound since 2022 last year, with CHF 2.95 billion invested and a record CHF 1.116 billion flowing into…
-
Read more: Bridging the tough middle: Key takeaways from the Deep-Tech x Space SummitESA chose ESDI at Park Innovaare for its first dedicated Deep-Tech × Space Summit on 13 May 2026. Deep Tech Nation Switzerland CEO Joanne Sieber…
-
Read more: SICTIC: A Matter of ScaleIn Parts 1 and 2 of our series, we followed Thomas Dübendorfer from a student fund at ETH Zurich to SICTIC, Switzerland’s largest angel investor…
-
Read more: SICTIC: Backed to the FutureThomas Dübendorfer doesn’t invest like a portfolio manager optimizing for returns. He invests like a scout who found someone worth running alongside – and then…
-
Vaderis Therapeutics closes USD 152 million Series B Financing
Basel-based Vaderis Therapeutics, a clinical-stage biopharmaceutical company focused on developing targeted therapies for rare vascular diseases, today announced the closing of a private $152 million…
startupticker.ch
startupticker.ch: Vaderis Therapeutics closes USD 152 million Series B Financing- Vaderis raised $152M in Series B funding to advance engasertib into Phase 3 trials for hereditary hemorrhagic telangiectasia (HHT).
- Engasertib, an oral AKT inhibitor, showed sustained improvements in HHT patients and could be the first approved HHT-specific therapy.
- The HEROIC Phase 3 study is a global, randomized, placebo-controlled trial for moderate-to-severe HHT across three continents.
-
Terra Quantum partners with Apex.AI on quantum-safe security
Swiss startup Terra Quantum and California-based Apex.AI have demonstrated a quantum-safe security solution for long-lived, cloud-connected software-defined systems. The joint solution is designed to help…
startupticker.ch
startupticker.ch: Terra Quantum partners with Apex.AI on quantum-safe security- Terra Quantum and Apex.AI demonstrated a quantum-safe security solution using NIST-standardized post-quantum cryptography.
- The solution maintains compatibility with existing software while preparing organizations for future quantum computing threats.
- Mission-critical aerospace, defense, and infrastructure systems need post-quantum security now as today's devices will outlast current standards.
-
Exclaim Robotics raises USD 4.95 million for data centre repair robots
Exclaim Robotics has emerged from stealth with a USD 4.95 million pre-seed round co-led by Founderful and Playfair. The Zurich-based startup is building autonomous mobile…
startupticker.ch
startupticker.ch: Exclaim Robotics raises USD 4.95 million for data centre repair robots- Exclaim Robotics raised $4.95M to build autonomous robots for hazardous maintenance tasks in AI data centres, addressing 800V DC power system safety risks.
-
Two Swiss biotechs clear US regulatory steps for heart and nerve therapies
HAYA Therapeutics has won Fast Track designation from the US Food and Drug Administration for its lead cardiac fibrosis candidate, while Oculis has received FDA…
startupticker.ch
startupticker.ch: Two Swiss biotechs clear US regulatory steps for heart and nerve therapies- HAYA Therapeutics received FDA Fast Track designation for HTX-001, an antisense oligonucleotide for cardiac fibrosis in hypertrophic cardiomyopathy.
- Oculis can cross-reference existing data to expand Privosegtor into acute multiple sclerosis relapse treatment, per FDA feedback.
- Privosegtor showed positive Phase 2 data in optic neuritis and uses the same 3mg/kg dose across MS relapse types.
-
AB2 Bio receives USD 30 million from Nippon Shinyaku
Lausanne-based AB2 Bio has received a USD 30 million payment after Japanese pharmaceutical company Nippon Shinyaku exercised its option to commercialise Tadekinig alfa in the…
startupticker.ch
startupticker.ch: AB2 Bio receives USD 30 million from Nippon Shinyaku- AB2 Bio received $30M from Nippon Shinyaku exercising its Tadekinig alfa US commercialization option, with up to $600M in milestone and royalty payments.
- Tadekinig alfa, a recombinant IL-18 binding protein, treats rare monogenic hyperinflammatory syndrome by neutralizing excess IL-18.
- The drug has FDA breakthrough therapy and rare pediatric disease designations, making it eligible for a priority review voucher.
-
Ahead Health raises USD 10 million and opens first markets outside Switzerland
Zurich-based Ahead Health has raised USD 10 million in a round led by Vienna-based 3VC and existing investor RTP Global, and is using the capital…
startupticker.ch
startupticker.ch: Ahead Health raises USD 10 million and opens first markets outside Switzerland- Ahead Health raised $10M led by 3VC and RTP Global to expand its AI preventive healthcare platform from Switzerland into Germany and the Netherlands.
- The platform combines full-body MRI, 80+ biomarker blood tests, and AI analysis to detect silent cardiovascular and metabolic diseases early.
- Ahead Health partners with 20+ clinics and labs, using repeat testing against individual baselines for personalized disease prevention.
-
Quantonation leads USD 25.5 million seed round for ETH spin-off ZuriQ
ZuriQ has raised USD 25.5 million in a seed round to scale the trapped-ion quantum processors it is building on a two-dimensional chip architecture. The…
startupticker.ch
startupticker.ch: Quantonation leads USD 25.5 million seed round for ETH spin-off ZuriQ- ZuriQ raised $25.5M for trapped-ion quantum processors using a novel 2D chip architecture eliminating junction bottlenecks.
- ZuriQ demonstrated a 3×3 array of nine controlled ions, the largest 2D trapped-ion array, using standard manufacturing.
- ZuriQ's static magnetic field design enables ions to move freely in any direction, overcoming 1D architecture limitations.
-
Neurimmune closes licensing deal of up to USD425 million
Neurimmune announced today that it has sold a portion of its royalty interest in cliramitug to Royalty Pharma for up to $425 million, including $125…
startupticker.ch
startupticker.ch: Neurimmune closes licensing deal of up to USD425 million- Neurimmune sold cliramitug royalty interest to Royalty Pharma for up to $425M, with $125M upfront.
- Non-dilutive funding supports Neurimmune's R&D while Alexion/AstraZeneca develops cliramitug for ATTR-CM.
- Royalty Pharma receives 3-4% royalties on cliramitug sales plus milestone payments.
-
Hilo closes Series B extension round to fuel US expansion
Hilo secured a Series B extension round, totaling $19 million in new funding and bringing its total funding to date to over $119 million. The…
startupticker.ch
startupticker.ch: Hilo closes Series B extension round to fuel US expansion- Hilo raised $19 million in Series B extension funding led by Dell Family Office, totaling $119 million.
- Hilo Core captures 30-35 daily blood pressure readings via wearables, addressing hypertension in nearly half of U.S.
- Hilo Core launches July 21, 2026 for $89.99 hardware plus $149.99 annual subscription, HSA and FSA eligible.
-
Swiss Startup Aionic Labs selected for funding initiative by Germany's federal agency SPRIN-D
Aionic Labs is one of ten selected teams for the "Next Frontier AI" funding initiative and will receive around three million euros in funding in…
startupticker.ch
startupticker.ch: Swiss Startup Aionic Labs selected for funding initiative by Germany's federal agency SPRIN-D- Aionic Labs secured €3M in initial funding from Germany's SPRIN-D to develop AI models for time series data, with potential total of €26.5M.
- Aionic Labs' Time-Series Language Models analyze sensor data from hospitals, factories, power grids, and finance to detect issues and aid decisions.
- Technology from ETH Zurich and Stanford research fills a gap: existing AI models struggle with continuous measurement and sensor signals.
-
AELER eyes oncoming large-scale roll-out
AELER, the Swiss start-up specializing in sustainable smart logistics, is set to scale up to industrial level in the coming months. To meet the demands…
startupticker.ch
startupticker.ch: AELER eyes oncoming large-scale roll-out- AELER raised over CHF 22 million since 2022 and appointed new CEO Benoit Dumont, former DHL regional CEO, for scaling.
- AELER's shipping container solution cuts logistics costs by 10-20% and CO₂ by 20%, with 95% gains in air-to-sea shifts.
- AELER doubled yearly shipment volumes, serves 10+ major clients including P&G, and partners with top-25 freight forwarder Rhenus.
-
CDDS secures seed capital for further development steps
Defense startup CDDS (Counter Defense Drone Systems) has secured Swisscom Ventures as an investor in a seed funding round. With the fresh capital, the startup…
startupticker.ch
startupticker.ch: CDDS secures seed capital for further development steps- CDDS, a Zurich defense startup founded in 2025, secured seed funding from Swisscom Ventures for autonomous kinetic interceptor drones.
- Small drones pose growing security threats to airports and energy facilities, creating demand for cost-effective defense solutions.
- CDDS manufactures interceptor drones with integrated chips and sensors across Switzerland, Norway, and partner facilities for scalable protection.
-
Read more: swisscanto: A Matter of Scale
The Flywheel Switzerland Hasn’t Built Roughly seventy percent of the Swiss Growth Fund’s money is invested in Switzerland, and Nils Granath is clear that this…
-
Read more: swisscanto: Backed to the Future
Three Companies That Almost Stopped Running Nils Granath invests in the growth stage of the Swiss market, and it is the part where the money…
-
Read more: swisscanto: At Face Value
The Marathon Runner In the mid-1990s, the European mobile telecoms industry was hiring at a pace that was breaking its own buildings. Ericsson, the Swedish…
-
Read more: Swiss Venture Capital Steadies at $1.58 Billion in H1 2026 as Hardware Sets a Record
Swiss venture capital returned to a familiar level in the first half of 2026. Startups raised $1.58 billion (CHF 1.245 billion) across 123 financing rounds,…
-
Read more: Swiss Deep Tech Report 2026: Switzerland Leads the Technologies Reshaping the Global Economy
The technologies now driving the global economy, advanced computing, artificial intelligence, and robotics, are built patiently, over decades of investment and scientific groundwork. So are…
-
Read more: Swiss Venture Capital Matures: Returns, Exits, and a Sharper Investor Layer
Swiss venture capital recorded its first annual rebound since 2022 last year, with CHF 2.95 billion invested and a record CHF 1.116 billion flowing into…
-
Read more: Bridging the tough middle: Key takeaways from the Deep-Tech x Space Summit
ESA chose ESDI at Park Innovaare for its first dedicated Deep-Tech × Space Summit on 13 May 2026. Deep Tech Nation Switzerland CEO Joanne Sieber…
-
Read more: SICTIC: A Matter of Scale
In Parts 1 and 2 of our series, we followed Thomas Dübendorfer from a student fund at ETH Zurich to SICTIC, Switzerland’s largest angel investor…
-
Read more: SICTIC: Backed to the Future
Thomas Dübendorfer doesn’t invest like a portfolio manager optimizing for returns. He invests like a scout who found someone worth running alongside – and then…
-
Read more: SICTIC: At Face ValueThe Very First Cheque When you ask investors at what point in their careers they wrote their first cheque, most will probably tell you a…
-
Read more: “Kick Ass Globally”: Inside Project Switzerland’s First Community GatheringOn April 30, 2026, the country’s most accomplished tech founders and the ten Scale-ups selected for the inaugural Project Switzerland cohort sat down together for…
-
Read more: AI in Switzerland: Stanford Data Confirms World Leading Talent DensityThe Stanford AI Index Report 2026, released in April 2026, ranks Switzerland first in the world for AI researchers and inventors per capita, with 110.5…
